The clinical characteristics and prognosis of endometrial carcinomas that occur after breast cancer: does hormone receptor status of breast cancer matter?-Reference-Cited by-同舟云学术

The clinical characteristics and prognosis of endometrial carcinomas that occur after breast cancer: does hormone receptor status of breast cancer matter?

Published:2019-10-01 Issue:5 Volume:300 Page:1399-1404
ISSN:0932-0067
Container-title:Archives of Gynecology and Obstetrics
language:en
Short-container-title:Arch Gynecol Obstet

Author:

Guo Jianbin,Zhang Ying^ORCID,Qian Haili,Ma Fei,Cui Xiujuan,Duan Hua

Funder

Beijing High-level Health Personnel Training Program

Publisher

Springer Science and Business Media LLC

Subject

Obstetrics and Gynecology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00404-019-05318-2.pdf

Reference30 articles.

1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 Cancers in 185 countries. CA Cancer J Clin 68(6):394–424

2. Ghoncheh Mahshid, Pournamdar Zahra, Salehiniya Hamid (2016) Incidence and mortality and epidemiology of breast cancer in the world. Asian Pac J Cancer Prev 17(S3):43–46

3. Early Breast Cancer Trialists Collaborative Group (1988) Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer. An overview of 61 randomized trials among 28,896 women. N Engl J Med 319(26):1681–1692

4. Fisher B, Costantino J, Redmond C, Poisson R, Bowman D, Couture J et al (1989) A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen receptor positive tumors. N Engl J Med 320(8):479–484

5. Winer EP, Hudis C, Burstein HJ, Wolff AC, Pritchard KI, Ingle JN et al (2005) American society of clinical oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: status report 2004. J Clin Oncol 23(3):619–629

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Construction of breast cancer-related gene prognostic signature in endometrial cancer;2024-05-10

2. The challenge of survivors of gynecological carcinomas: a retrospective study on occurrence of second tumors;Archives of Gynecology and Obstetrics;2024-05-06

3. Endometrial pathologies in clinical follow-up of patients with hormone receptor-positive/negative breast cancer;Journal of Surgery and Medicine;2023-12-07

4. Common Multiple Primary Cancers Associated With Breast and Gynecologic Cancers and Their Risk Factors, Pathogenesis, Treatment and Prognosis: A Review;Frontiers in Oncology;2022-06-08

5. Neural plasticity of the uterus: New targets for endometrial cancer?;Women's Health;2022-01